GDF-15 AS A DIAGNOSTIC MARKER TO PREDICT THE CLINICAL OUTCOME OF A TREATMENT WITH IMMUNE… Application EP-4321866-A2 European Patent Office 14 Feb 2024
CORE/SHELL STRUCTURE PLATFORM FOR IMMUNOTHERAPY Application EP-4309739-A2 European Patent Office 24 Jan 2024
NEOANTIGEN IDENTIFICATION, MANUFACTURE, AND USE Application EP-4299136-A2 European Patent Office 03 Jan 2024
Compositions and methods for delivery of biomacromolecule agents Grant US-11833196-B2 United States of America 05 Dec 2023
Checkpoint blockade and microsatellite instability Grant US-11753468-B2 United States of America 12 Sep 2023
Checkpoint blockade and microsatellite instability Grant US-11718668-B2 United States of America 08 Aug 2023
COMBINATION THERAPY USING INHIBITORS OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15… Application EP-4218809-A2 European Patent Office 02 Aug 2023
Proteogenomic-based method for identifying tumor-specific antigens Grant US-11702450-B2 United States of America 18 Jul 2023
Checkpoint blockade and microsatellite instability Grant US-11649287-B2 United States of America 16 May 2023
Checkpoint blockade and microsatellite instability Grant US-11643462-B2 United States of America 09 May 2023
Checkpoint blockade and microsatellite instability Grant US-11634491-B2 United States of America 25 Apr 2023
Checkpoint blockade and microsatellite instability Grant US-11629187-B2 United States of America 18 Apr 2023
Checkpoint blockade and microsatellite instability Grant US-11591393-B2 United States of America 28 Feb 2023
PERSONALIZED VACCINE ADMINISTRATION Application WO-2023281418-A1 World Intellectual Property Organisation (WIPO) 12 Jan 2023
ADMINISTRATION OF NAKED NUCLEIC ACID MOLECULE Application WO-2023281419-A2 World Intellectual Property Organisation (WIPO) 12 Jan 2023
CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY Application EP-4098278-A1 European Patent Office 07 Dec 2022
COMBINATION THERAPY USING INHIBITORS OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15… Grant EP-3355919-B1 European Patent Office 07 Dec 2022
Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15… Grant US-11464856-B2 United States of America 11 Oct 2022
Anti-tissue factor antibodies, antibody-drug conjugates, and related methods Grant US-11447566-B2 United States of America 20 Sep 2022
Core/shell structure platform for immunotherapy Grant US-11382964-B2 United States of America 12 Jul 2022
CORE/SHELL STRUCTURE PLATFORM FOR IMMUNOTHERAPY Application EP-4008344-A1 European Patent Office 08 Jun 2022
REUSABLE CARTRIDGES FOR DETECTING ANALYTES IN SOLUTION Application WO-2022109087-A1 World Intellectual Property Organisation (WIPO) 27 May 2022
Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist… Grant US-11338027-B2 United States of America 24 May 2022
Checkpoint blockade and microsatellite instability Grant US-11339219-B2 United States of America 24 May 2022
Checkpoint blockade and microsatellite instability Grant US-11325974-B2 United States of America 10 May 2022
Checkpoint blockade and microsatellite instability Grant US-11325975-B2 United States of America 10 May 2022
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune… Grant US-11262360-B2 United States of America 01 Mar 2022
Compositions and methods for delivery of biomacromolecule agents Grant US-11219673-B2 United States of America 11 Jan 2022
CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY Application EP-3888679-A1 European Patent Office 06 Oct 2021
Heat shock protein-binding peptide compositions and methods of use thereof Grant US-11065317-B2 United States of America 20 Jul 2021
Determinants of cancer response to immunotherapy by PD-1 blockade Grant US-10993998-B2 United States of America 04 May 2021
Methods and systems for predicting response to immunotherapies for treatment of cancer Grant US-10969392-B2 United States of America 06 Apr 2021
Checkpoint blockade and microsatellite instability Grant US-10934356-B2 United States of America 02 Mar 2021
Neoantigen identification, manufacture, and use Grant US-10847252-B2 United States of America 24 Nov 2020
Neoantigen identification, manufacture, and use Grant US-10847253-B2 United States of America 24 Nov 2020
Recombinant polypeptides and methods of use thereof Grant US-10675332-B1 United States of America 09 Jun 2020
Vaccines for treatment and prevention of cancer Grant US-10568948-B2 United States of America 25 Feb 2020
Neoantigen treatment prioritization using multivariate analysis based on: HLA genotype… Grant US-10563266-B2 United States of America 18 Feb 2020
A SYSTEM FOR IDENTIFICATION OF ANTIGENS RECOGNIZED BY T CELL RECEPTORS EXPRESSED ON TUMOR… Application WO-2019238939-A1 World Intellectual Property Organisation (WIPO) 19 Dec 2019
ANTIGENIC PEPTIDES DERIVING FROM SECRETOGRANIN V AND USES THEREOF FOR THE DIAGNOSIS AND… Application WO-2019175380-A2 World Intellectual Property Organisation (WIPO) 19 Sep 2019
ANTIGENIC PEPTIDES DERIVING FROM UROCORTIN 3 AND USES THEREOF FOR THE DIAGNOSIS AND… Application WO-2019175384-A2 World Intellectual Property Organisation (WIPO) 19 Sep 2019
ANTIGENIC PEPTIDES DERIVING FROM PCSK2 AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT… Application WO-2019175381-A1 World Intellectual Property Organisation (WIPO) 19 Sep 2019
Recombinant polypeptides and methods of use thereof Grant US-10370421-B2 United States of America 06 Aug 2019
Recombinant polypeptides and methods of use thereof Grant US-10351607-B1 United States of America 16 Jul 2019
Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines… Grant US-10350280-B2 United States of America 16 Jul 2019
Recombinant polypeptides and methods of use thereof Grant US-10323071-B1 United States of America 18 Jun 2019
Liposomal particles comprising biological molecules and uses thereof Application US-10307491-B2 United States of America 04 Jun 2019
Recombinant polypeptides and methods of use thereof Grant US-10301364-B1 United States of America 28 May 2019
Recombinant polypeptides and methods of use thereof Grant US-10150801-B1 United States of America 11 Dec 2018
METHODS FOR IDENTIFYING AND MODULATING CO-OCCURANT CELLULAR PHENOTYPES Application WO-2018170515-A1 World Intellectual Property Organisation (WIPO) 20 Sep 2018
Neoantigen identification, manufacture, and use Application US-10055540-B2 United States of America 21 Aug 2018
CORE/SHELL STRUCTURE PLATFORM FOR IMMUNOTHERAPY Application WO-2018140826-A1 World Intellectual Property Organisation (WIPO) 02 Aug 2018
VIRAL DELIVERY OF NEOANTIGENS Application WO-2018098362-A1 World Intellectual Property Organisation (WIPO) 31 May 2018
GDF-15 as a diagnostic marker for predicting the clinical course of treatment with immune… Application KR-20180054867-A Republic of Korea 24 May 2018
METHODS FOR IDENTIFYING AND MODULATING CO-OCCURANT CELLULAR PHENOTYPES Application WO-2017161325-A1 World Intellectual Property Organisation (WIPO) 21 Sep 2017
PEPTIDE VACCINES COMPRISING SELF-ASSEMBLING POLYMER NANOPARTICLES Application WO-2017147597-A1 World Intellectual Property Organisation (WIPO) 31 Aug 2017
TRANSINFECTED LYMPHOCYTES FOR ANTI-TUMOR THERAPY Application WO-2017025657-A1 World Intellectual Property Organisation (WIPO) 16 Feb 2017
NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF Application WO-2016127249-A1 World Intellectual Property Organisation (WIPO) 18 Aug 2016